April 14, 2015 / 2:03 PM / 3 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Dover Saddlery, Brainstorm, JPMorgan

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks edged higher at the open on Tuesday, buoyed by gains in JPMorgan Chase after the bank posted quarterly earnings, while energy stocks advanced as oil prices climbed. The Dow Jones industrial average was down 0.03 percent at 17,971.31 and the S&P 500 was down 0.16 percent at 2,089.09.

** JPMORGAN CHASE & CO, $63.33, +2.03 pct

JPMorgan, the biggest U.S. bank by assets, reported a 12.2 percent rise in quarterly profit as revenue from fixed-income trading rebounded.

For a graphic: here

** NOKIA OYJ, $7.89, -4.94 pct

** ALCATEL-LUCENT SA, $4.7, +8.05 pct

Nokia is in talks to buy smaller telecom equipment maker Alcatel-Lucent, a deal that would combine the industry’s two weakest players but could pose challenges in cutting costs and overcoming political opposition.

** DOVER SADDLERY INC, $8.4, +68.00 pct

The company agreed to be taken private by private equity firm Webster Capital for $8.50 per share in cash.


The drugmaker said it expects to present positive data from a mid-stage study of its treatment for amyotrophic lateral sclerosis, a neurological disease that weakens muscles and impacts physical function.

** GW PHARMACEUTICALS PLC, $101.03, +5.04 pct

The drugmaker’s childhood epilepsy drug, epidiolex, currently in use through an expanded access program, showed marked improvement in median reduction of seizure frequency, data compiled by American Society Of Neurology shows.

** AETERNA ZENTARIS INC, $0.5739, +6.57 pct

Analysts at HC Wainwright raise rating on the drug developer’s stock to “buy” from “neutral” after the company says it plans to conduct a confirmatory study on hormone deficiency drug-test after meeting with the U.S. Food and Drug Administration.


Imperial Capital raises rating on the energy-focused construction company’s stock to “outperform” from “in-line”.

** NORFOLK SOUTHERN CORP, $98.36, -6.21 pct

At least four brokerages cut their price targets on the U.S. railroad company by as much as $10 to as low as $105. Norfolk said on Monday that it expected first-quarter EPS to fall 15 percent and revenue to drop 5 percent due to reduced fuel surcharge revenue and lower coal volumes. (Compiled by Anannya Pramanick in Bengaluru; Edited by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below